According to Ernst & Young, biotechnology companies worldwide boosted profit by 37 percent to a record $5.2 billion in 2012, in part by tempering growth in research-and-development spending.

Embedded Link

Biotechnology Draws Record Profit as Research Money Slows
Biotechnology companies worldwide boosted profit by 37 percent to a record $5.2 billion in 2012, partly by tempering growth in research-and-development spending, according to Ernst & Young.

Google+: View post on Google+

Tags:

Comments are closed.